Theravance Biopharma Aktie
15,40
EUR
-0,30
EUR
-1,91
%
18,13
USD
-0,57
USD
-3,05
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung